Reliability of resting-state electrophysiology in fragile X syndrome
Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Biomarkers in Neuropsychiatry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666144623000102 |